Legislation & Regulation
Richard Mark Kirkner

Dick Woodruff

The NIH would get a $9 billion shot in the arm, but some fear the FDA provisions will mean lax oversight of drugs and devices.

Tomorrow's Medicine
Thomas Morrow, MD

Brace yourself for astronomically priced injections. One on track for U.S. approval looks to treat a rare form of retinal disease.

News & Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report